SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 38.07 |
| Enterprise Value ($M) | 4.05 |
| Book Value ($M) | 18.20 |
| Book Value / Share | 3.75 |
| Price / Book | 2.09 |
| NCAV ($M) | 17.55 |
| NCAV / Share | 3.61 |
| Price / NCAV | 2.17 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.90 |
| Return on Assets (ROA) | -0.32 |
| Return on Equity (ROE) | -0.53 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.00 |
| Current Ratio | 8.01 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 36.37 |
| Assets | 37.02 |
| Liabilities | 18.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 4.50 |
| Operating Income | -18.01 |
| Net Income | -16.55 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -17.12 |
| Cash from Investing | 0.53 |
| Cash from Financing | -0.15 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,856 | 19,875 | 14.37 | |
| 3,623 | 3,218 | 112.59 | |
| 5,029 | 48,543 | 10.36 | |
| 1,060 | 1,699 | 62.39 | |
| 126 | 1,179 | 10.69 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ADIL – Adial Pharmaceuticals, Inc. | ADTX – Aditxt, Inc. |
| ADVM – Adverum Biotechnologies, Inc. | AGEN – Agenus Inc. |
| AIMD – Ainos, Inc. |